Across the recent three months, 6 analysts have shared their insights on Cushman & Wakefield (NYSE:CWK), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 2 | 2 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 0 | 1 | 0 | 0 |
3M Ago | 1 | 2 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $17.58, a high estimate of $20.00, and a low estimate of $15.00. Surpassing the previous average price target of $14.38, the current average has increased by 22.25%.
Decoding Analyst Ratings: A Detailed Look
The analysis of recent analyst actions sheds light on the perception of Cushman & Wakefield by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Alex Kramm | UBS | Raises | Neutral | $17.00 | $12.00 |
Anthony Paolone | JP Morgan | Raises | Neutral | $20.00 | $13.00 |
Julien Blouin | Goldman Sachs | Raises | Buy | $20.00 | $17.50 |
Julien Blouin | Goldman Sachs | Announces | Buy | $17.50 | - |
Mitch Germain | JMP Securities | Raises | Market Outperform | $16.00 | $15.00 |
Mitch Germain | JMP Securities | Announces | Market Outperform | $15.00 | - |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cushman & Wakefield. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cushman & Wakefield compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Cushman & Wakefield's stock. This analysis reveals shifts in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Cushman & Wakefield's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Cushman & Wakefield analyst ratings.
Delving into Cushman & Wakefield's Background
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.
Cushman & Wakefield: Delving into Financials
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Cushman & Wakefield showcased positive performance, achieving a revenue growth rate of 8.56% as of 30 June, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: Cushman & Wakefield's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.31% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Cushman & Wakefield's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.11%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Cushman & Wakefield's ROA excels beyond industry benchmarks, reaching 0.77%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.7, Cushman & Wakefield faces challenges in effectively managing its debt levels, indicating potential financial strain.
What Are Analyst Ratings?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.